SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLDX Celldex Therapeudics
CLDX 26.71+2.7%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: wood_ny who wrote (70)6/6/2020 10:11:15 PM
From: Miljenko Zuanic  Read Replies (1) of 105
 
Wiki and Mast cell leukemia:
en.wikipedia.org
<Tumor markers[ edit]The leukemic cells usually are strongly positive for CD13, CD33, CD68, and CD117. Characteristically, basophil (e.g. CD11b, CD123) and monocyte markers ( CD14, CD15) are absent. The cells usually express CD2 and CD25. [9] Malignant mast cells overexpress the anti-apoptosis gene, bcl-2. [10] A mutation called KIT mutation is detected in most patients. [11]>



So, it is possibility and anti-KIT Abs may be active!

How did you come to this *option*?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News